IP Verse

Daiichi Sankyo competitive analysis

Latest publications and patents of Daiichi Sankyo New

Explore the latest publications and patents granted to Daiichi Sankyo, showcasing their recent innovations and technological advancements.

Last updated on: Oct 1, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Daiichi Sankyo

EP2140867
Aug 16, 2023Pharmaceutical CompositionPatent Maintained As Amended
EP3196304
Oct 6, 2021Method For Improved High Secretory Production Of ProteinsGranted And Under Opposition
EP3121274
Dec 18, 2019Method For Predicting Responsiveness To Cancer Treatment Using P300-Inhibiting CompoundGranted And Under Opposition
EP2974730
Jan 31, 2018Drug For Respiratory DiseasesNo Opposition Filed Within Time Limit
EP2985277
Jan 17, 2018Dipyrromethene Crystal And Method For Manufacturing SameNo Opposition Filed Within Time Limit
EP3040330
Jan 10, 2018Method For Producing Pyrrole Derivative, And Intermediate ThereofNo Opposition Filed Within Time Limit
EP2832857
Jan 3, 2018Anti-Siglec15 Antibody With Modified CdrNo Opposition Filed Within Time Limit

Latest patents of Daiichi Sankyo opposed by its competitors

Explore Daiichi Sankyo's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2140867
Aug 16, 2023Pharmaceutical Composition2
EP3196304
Oct 6, 2021Method For Improved High Secretory Production Of Proteins1
EP3121274
Dec 18, 2019Method For Predicting Responsiveness To Cancer Treatment Using P300-Inhibiting Compound1

Latest PTAB cases involving Daiichi Sankyo

Discover the latest PTAB cases involving Daiichi Sankyo, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 7, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Daiichi Sankyo

PGR2023-00037Jun 16, 2023ONCUSP THERAPEUTICSDAIICHI SANKYOTerminated-Settled
PGR2021-00042Jan 22, 2021DAIICHI SANKYOSEAGENTerminated-Adverse Judgment
PGR2021-00030Dec 23, 2020DAIICHI SANKYOSEAGENFinal Written Decision - Appealed
IPR2015-01882Oct 5, 2015LUPINDAIICHI SANKYOFinal Written Decision
IPR2015-01881Oct 5, 2015LUPINDAIICHI SANKYOFinal Written Decision
IPR2015-01496Jun 26, 2015PANACEA BIOTECDAIICHI SANKYOInstitution Denied
IPR2015-01492Jun 26, 2015PANACEA BIOTECDAIICHI SANKYOInstitution Denied
IPR2015-00865Mar 13, 2015ACCORD HEALTHCAREDAIICHI SANKYOFinal Written Decision
IPR2015-00864Mar 12, 2015ACCORD HEALTHCAREDAIICHI SANKYOFinal Written Decision
IPR2015-00291Nov 25, 2014DAIICHI SANKYOALETHIA BIOTHERAPEUTICSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Daiichi Sankyo with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
DAIICHI SANKYO - 437Defensive
ACCORD HEALTHCARE34 - 4 - Highly Aggressive
LUPIN - 115 - Highly Aggressive
PANACEA BIOTEC - - 2 - Highly Aggressive